TNFRSF1B and urogenital neoplasm: Research revealed that their metabolic products may be involved in the reduction of the inflammatory factor TNF-α and its membrane receptor TNF-R2, which may be related to the protective capacity of the phylum Verrucomicrobia against prostatitis.